Skip to main content

Herd Immunity

Herd Immunity: What is it and will it Help Slow the Spread of COVID-19

      Many countries are enforcing strict social distancing and shelter-in-place regulations to slow the spread of COVID-19. However, other countries such as Sweden and briefly Britain are taking a completely different approach. Sweden has been resisting shelter-in-place orders in hope of achieving herd immunity before a vaccine is developed. This approach of course, comes with consequences. Sweden has one of the highest mortality rates in the world and their approach to herd immunity is going very slowly. So, what is herd immunity and is it achievable?

What is Herd Immunity

    Herd immunity occurs when enough of a population is immune to a disease that it won't spread very far to those who aren't immune. This immunity can be developed if the person has already been exposed to the disease or has been vaccinated. For example, if 70% of a population is immune to a virus, 7 out of 10 people who encounter someone with the disease won't become infected and won't spread the disease any further. 

What is Needed to Achieve Herd Immunity

    For a virus like COVID-19, experts predict that about 60-70% of the population needs to be immune in order for herd immunity to occur. According to a Swedish Study, only 7% of the population in Stockholm has developed an immunity to the disease from March to the end of April. Other cities don't seem to be doing much better either. New York City has the highest amount of antibodies developed at 19.9% (See figure below). This number is still far from the required 60% minimum. 

Popovich, Nadja, and Margot Sanger-katz. “The World Is Still Far From Herd Immunity for Coronavirus.” The New York Times, The New York Times, 28 May 2020, www.nytimes.com/interactive/2020/05/28/upshot/coronavirus-herd-immunity.html?campaign_id=9&emc=edit_nn_20200529&instance_id=18910&nl=the-morning®i_id=104079047&segment_id=29522&te=1&user_id=a1ffb30ce1c80314068039118d254073.

Is Herd Immunity Achievable 

    According to results from multiple studies, it can be concluded that herd immunity is not the best approach to slowing the spread of the coronavirus and is unlikely to be achieved any time soon. Herd immunity has been developed for other infections such as measles and chicken pox with the help of vaccines. However, with COVID-19 being a much more severe disease and without a vaccine,  the risk of death that comes with attaining herd immunity is just too high. According to Michael Mina, an epidemiologist at Harvard, "We don't have a good way to safely build it up, to be honest, not in the short term". 

Sources

  1. Lindsay Smith Rogers, and JH Bloomberg School of Public Health. “What Is Herd Immunity and How Can We Achieve It With COVID-19?” Johns Hopkins Bloomberg School of Public Health, 22 Apr. 2020, www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html.

  2. TodayShow. “What Is Herd Immunity and When Will We Get There for Coronavirus?” TODAY.com, 2 June 2020, www.today.com/health/what-herd-immunity-when-will-it-be-achieved-coronavirus-covid-t183014.

  3. Popovich, Nadja, and Margot Sanger-katz. “The World Is Still Far From Herd Immunity for Coronavirus.” The New York Times, The New York Times, 28 May 2020, www.nytimes.com/interactive/2020/05/28/upshot/coronavirus-herd-immunity.html?campaign_id=9&emc=edit_nn_20200529&instance_id=18910&nl=the-morning®i_id=104079047&segment_id=29522&te=1&user_id=a1ffb30ce1c80314068039118d254073.

Comments

Popular posts from this blog

Efficacy of Masks

Do Wearing Masks Really Prevent Coronavirus            For weeks, U.S. health authorities discouraged healthy Americans from wearing masks, believing they would do more harm than good. However, other countries such as China and South Korea have required all citizens to wear a mask when entering a public setting to prevent the spread of the coronavirus. But really how effective are these masks against the coronavirus? On April 3rd, Nature Medicine published an article describing their findings based off an experiment testing the efficacy of surgical face masks against coronavirus, influenza virus and rhinovirus.   Study Findings      Their results demonstrated that surgical masks were largely effective in reducing coronavirus transmission through respiratory droplets as well as aerosol particles. Three out of ten people who did not wear a mask were infected with the coronavirus through droplet particles. Out of eleven people w...

Breakthrough Infections

 COVID-19 Breakthrough Infections     As of August 2021, a little over 50% of the U.S. population has been fully vaccinated against COVID-19. However, despite the increasing number of vaccinated individuals and high efficacy of the vaccines, rare breakthrough cases have occurred. With the reports of breakthrough cases, or instances when people who are fully vaccinated get infected with COVID-19, many questions have arisen. How common are breakthrough infections? What are the symptoms? How severe are the cases? These questions are addressed in a peer-reviewed study investigating breakthrough cases among healthcare workers in Israel. The study was recently published in the New England Journal of Medicine on July 28, 2021.  About the Study     The study setting took place in the Sheba Medical Center, which is the largest medical center in Israel staffed with 12,586 healthcare workers. By April 28, 2021, 11,453 workers (91%) had been fully vaccinated with the ...

Plasma for COVID-19 treatment

FDA Authorizes Plasma for COVID-19 Treatment                     COVID-19, which has been spreading across the globe since March, has affected the lives of Americans for over six months. Many people, including the President, are eager to eliminate the virus after a dreadful 6 months of rising cases and quarantine. To their dismay, hopes of eliminating the virus by Easter and then by August, seemed to turn into an unreachable dream for Americans. With cases rising and no sure vaccine or treatment for the virus, a future without COVID-19 seemed further and further away. Yet, this Sunday on August 23, 2020, the U.S. Food and Drug Administration authorized the first treatment for COVID-19: convalescent plasma. While the plasma has only been authorized for emergency use, many people see this authorization as progress towards eliminating the virus. However, others believe that the plasma is not as effective, and that the FDA was pres...